Nachrichten zur Abbvie Inc. Aktie

S&P 500-Titel AbbVie-Aktie: So viel Gewinn hätte ein Investment in AbbVie von vor 5 Jahren eingefahren

Heute vor 5 Jahren wurden AbbVie-Anteile an der Börse NYSE gehandelt. Zur Schlussglocke war das Papier an diesem Tag…

AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised

ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.…

AbbVie Aktie: Gewinnerwartungen übertroffen - Aktie fällt trotz starker Ergebnisse

Frankfurt (www.aktiencheck.de) - AbbVie-Aktienanalyse von XTB:Die Experten von XTB nehmen die Aktie von AbbVie Inc. (ISIN: US00287Y1091, WKN: A1J84E, Ticker-Symbol:…

AbbVie (ABBV) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed in the quarter…

AbbVie Aktie: Skyrizi und Rinvoq treiben Umsatz kräftig an - Jahresprognose leicht angehoben

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

AbbVie Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEFriday, Oct. 31, 2025 at 9 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Robert A.…

AbbVie lifts annual profit forecast on resilient demand for newer immunology drugs

AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped boost…

Schwab U.S. Dividend Quality ETF (SCHD) Offers Higher Yield While Fidelity High Dividend ETF (FDVV) Leans Into Tech

Key PointsSCHD and FDVV diverge on sector tilts, yield, and fees.Schwab U.S. Dividend Equity ETF (SCHD) offers a higher payout…

Railway Pension Loads Up With 240,000 Mastercard (MA) Shares in Q3

Key PointsRailway Pension increased its Mastercard stake by 240,000 shares; an estimated $137.83 million trade based on the quarterly average…

ONEOK’s 6% Dividend Draws Smart Money Despite a Nearly 30% Drop

Key PointsSouth Carolina-based Apricus Wealth added 42,386 shares of ONEOK for an estimated $3.3 million during the third quarter.The transaction…

Why Some Investors Are Taking Profits on JPMorgan After Its Big Rally

Key PointsSouth Carolina-based Apricus Wealth sold 10,784 shares of JPMorgan Chase & Co. for an estimated $3.2 million in the…

Is Fiserv a Buy After Letson Investment Management Initiated a Big Position in the Stock?

Key PointsLetson Investment Management acquired 73,166 shares of Fiserv with an estimated trade size of $9.43 million as of September…

AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.…

AbbVies Rinvoq gains updated indication for ulcerative colitis, Crohns

…

AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?

ABBV shares rose 6% last week as optimism swept the pharma sector after Pfizers landmark drug-pricing deal with the Trump…

AbbVie expects $2.7 billion R&D charge in third quarter By Reuters

AbbVie expects $2.7 billion R&D charge in third quarter…

St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy

Key PointsAdded 14,630 shares of AbbVie, an estimated $3.39 million trade based on average pricing for Q3 2025Transaction represents 2.2%…

Eli Lilly and Its Competitors Pop on the Pfizer News

Market Analysis by covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, AbbVie Inc. Read s Market…

AbbVie (ABBV) Stock Sinks As Market Gains: Heres Why

In the closing of the recent trading day, AbbVie (ABBV) stood at $236.56, denoting a -3.2% move from the preceding…

US-Deal mit Pfizer beflügelt Pharmawerte - Nike kann den Umsatzrückgang stoppen

Wien (www.aktiencheck.de) - Nach dem Deal zwischen Pfizer (+6,8%) und der US-Regierung konnten Unsicherheiten bezüglich Zöllen und Preisrisiken branchenweit ein…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever @themotleyfool #stocks $ABBV $^GSPC $KO $CVX

If you are looking for dividend stocks that can provide a reliable, long-term income stream, consider buying AbbVie, Coca-Cola, and…

AbbVie Seeks FDA Nod for Tavapadon to Treat Parkinsons Disease

ABBV files for FDA approval of tavapadon, a once-daily oral Parkinsons drug backed by late-stage TEMPO studies.…

AbbVie to launch ovarian cancer drug in UK at the same list price as US

AbbVie said on Monday it would launch its ovarian cancer drug Elahere in the U.K. at a list price equal…

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…

Top Analyst Reports for AbbVie, ServiceNow & Boeing

AbbVie, ServiceNow, and Boeing outpace their industries as analysts highlight growth drivers and risks in fresh research reports.…

AbbVie stock hits all-time high at 221.8 USD By Investing.com

AbbVie stock hits all-time high at 221.8 USD…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…